Owens & Minor, Inc. (OMI) is a publicly traded Healthcare sector company. As of May 21, 2026, OMI trades at $2.80 with a market cap of $216.57M and a P/E ratio of -0.20. OMI moved +2.19% today. Year to date, OMI is -48.62%; over the trailing twelve months it is -77.88%. Its 52-week range spans $2.38 to $16.38. Analyst consensus is hold with an average price target of $4.00. Rallies surfaces OMI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Owens & Minor Completes $375M Sale of P&HS Segment, Rebrands as Accendra Health: Owens & Minor sold its Products & Healthcare Services segment and brand to Platinum Equity for $375 million in cash, retaining a 5% stake and preserving over $150 million in tax attributes. It will rename the parent Accendra Health and focus on home-based care with Apria and Byram brands.
| Metric | Value |
|---|---|
| Price | $2.80 |
| Market Cap | $216.57M |
| P/E Ratio | -0.20 |
| EPS | $-14.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.38 |
| 52-Week Low | $2.38 |
| Volume | 1.27M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.72B |
| Net Income | $-1.08B |
| Gross Margin | 45.95% |
10 analysts cover OMI: 0 strong buy, 3 buy, 5 hold, 2 sell, 0 strong sell. Consensus rating is hold. Average price target: $4.00.